<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02244671</url>
  </required_header>
  <id_info>
    <org_study_id>13.27</org_study_id>
    <nct_id>NCT02244671</nct_id>
  </id_info>
  <brief_title>Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)</brief_title>
  <official_title>Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fox, Donald Munro, M.D., P.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fox, Donald Munro, M.D., P.C.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      immobilization of yoked extra-ocular muscles in the anophthalmic orbit, in conjunction with
      platelet-rich-plasma, will improve integration of viable adipocytes injected into orbital fat
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Immobilization of tissue (graft, graft bed) is a prerequisite for tissue integration. Since
      yoked extra-ocular muscles continue to be stimulated by movements of the seeing eye after fat
      injection into the anophthalmic orbit, the use of botulinum toxin(s) can be used to prevent
      movement of the orbital tissue bed(s) and improve anchoring of injected fat. Platelet rich
      plasma may also improve fat cell anchoring by the action of fibrin on the adhesion process.
      This innovation builds on the results of IRB protocols 10.27 and 12.01 as registered with
      Clinical Trials.gov
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Orbital volume</measure>
    <time_frame>one year</time_frame>
    <description>Augmentation of orbital volume accessed with clinical photographs and non-contrast MRI</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Orbital Atrophy</condition>
  <arm_group>
    <arm_group_label>fat, PRP, botulinum toxin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fat injection with platelet-rich-plasma (PRP) after immobilizing the extraocular muscles with botulinum toxin</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fat, PRP, botulinum toxin</intervention_name>
    <description>fat injection with platelet-rich-plasma (PRP) after immobilizing the extraocular muscles with botulinum toxin</description>
    <arm_group_label>fat, PRP, botulinum toxin</arm_group_label>
    <other_name>fat atrophy, absence of original eye, phthisis bulbi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>botulinum toxin</intervention_name>
    <description>botulinum toxin used to immobilize extra-ocular muscles prior to fat injection.</description>
    <arm_group_label>fat, PRP, botulinum toxin</arm_group_label>
    <other_name>botulinum toxins</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PRP</intervention_name>
    <description>autologous PRP is prepared with a dedicated centrifuge at the time of fat harvesting</description>
    <arm_group_label>fat, PRP, botulinum toxin</arm_group_label>
    <other_name>platelet rich plasma</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  anophthalmic enophthalmos in subjects within a 50 mile radius of New York City, grade
             0-1 anesthesia risk, ages 21-75

        Exclusion Criteria:

          -  radiated orbits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald M Fox, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Eye and Ear Infirmary</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Donald M Fox, MD</last_name>
    <phone>(212)772-1500</phone>
    <email>dmfmdjr@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York Eye and Ear Infirmary</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald M Fox, MD</last_name>
      <phone>212-772-1500</phone>
      <email>dmfmdjr@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Donald M Fox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.newyorkfami.com</url>
    <description>fat grafting</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2014</study_first_submitted>
  <study_first_submitted_qc>September 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2014</study_first_posted>
  <last_update_submitted>March 8, 2017</last_update_submitted>
  <last_update_submitted_qc>March 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

